Intravascular Lymphoma as a Cause of Respiratory Failure  by Nelson, Darlene R. et al.
e34 Journal of Thoracic Oncology  •  Volume 7, Number 12, December 2012
Intravascular large B-cell lymphoma (IVL) is a rare subtype of non-Hodgkin’s lymphoma which is characterized by pro-
liferation of malignant cells within the lumen of small blood 
vessels. We present a rare description of a case of fatal IVL 
associated with hypoxemia, pulmonary arterial hypertension 
(PAH), and shock.
CASE PRESENTATION 
A 68-eight-year-old man presented with a 3-month his-
tory of dyspnea, fatigue, and fevers. Review of systems was 
positive for anorexia, 40-lb weight loss, night sweats, head-
ache, and depression. Physical exam revealed a grade 3/6 sys-
tolic ejection murmur. Significant laboratory studies showed 
hemoglobin 9.6 µg/dL, mean corpuscular volume 84.7, 
erythrocyte sedimentation rate 120 mm/hr, C-reactive pro-
tein 159 mg/L, lactate dehydrogenase 576 U/L, and ferritin 
1313 g/L. Investigations for infection and autoimmune mark-
ers were negative. Pulmonary function tests showed a diffus-
ing capacity of the lung for carbon monoxide adjusted for 
hemoglobin that was reduced (48%), and desaturation with 
exercise (87%). Computed tomography of the chest with con-
trast was negative for pulmonary emboli and demonstrated 
only mild centrilobular emphysema and calcified granulo-
mas. Echocardiogram with bubble study was performed and 
demonstrated no significant shunt. There was no evidence 
of fluorodeoxyglucose (FDG)-avid malignancy or vasculitis 
on positron emission tomography (PET) scan. In addition, 
a bone-marrow biopsy was performed and demonstrated no 
evidence of malignancy. Empiric treatment with antibiotics 
and steroids were initiated without clinical improvement. He 
was readmitted 1 month later for worsening hypoxia, fatigue, 
and delirium and subsequently developed acute shock and 
hypoxemic respiratory failure. An echocardiogram dem-
onstrated acute right ventricular failure, D-shaped left ven-
tricle, and right ventricular systolic pressure of 56 mmHg 
(systolic blood pressure 73 mmHg). Pulmonary embolism 
with obstructive shock was suspected and thrombolytics 
were administered. Despite aggressive treatment, the patient 
died after pulseless arrest with failed resuscitation. Autopsy 
revealed multiorgan involvement of IVL and diffuse alveolar 
damage with in-situ thrombosis. (Fig. 1) In the absence of 
other etiologies we hypothesize that IVL was the cause of 
his diffuse alveolar damage, hypoxemic respiratory failure, 
and PAH.
DISCUSSION
IVL is a rare malignant lymphoma characterized by 
the selective growth of neoplastic cells within blood vessel 
lumina, particularly small vessels, for example, capillaries. It 
commonly affects the vessels of the skin and central nervous 
system and is associated with an aggressive clinical course.1 
Early systemic chemotherapy has been shown to improve sur-
vival.2 Primary pulmonary involvement is difficult to detect 
premortem.3 FDG-PET has been suggested as a useful diag-
nostic test, however, the reported sensitivity is low.4 Random 
transbronchial lung biopsies may be diagnostic even when the 
FDG-PET is negative5 and are useful in the diagnosis of IVL 
with pulmonary involvement.
Our patient presented with pulmonary involvement 
and developed hypoxemic respiratory failure, PAH, and 
shock. PAH has rarely been described as a complication of 
IVL. Autopsy revealed the etiology of our patient’s PAH was 
secondary to diffuse alveolar damage with in situ thrombus 
and partial or complete obstruction of pulmonary arteri-
oles and capillaries by large lymphoma cells. This clinically 
resulted in hypoxemia, acute right heart failure, and obstruc-
tive shock. In retrospect, the diagnosis may have been made 
by obtaining random transbronchial lung biopsies despite 
negative FDG-PET imaging.
In summary, IVL is a diagnostically challenging yet 
treatable disease for which primary presentations of hypoxemic 
respiratory failure are rare. Clinicians should consider IVL 
when treating patients with unknown etiology for hypoxemic 
respiratory failure with acute and subacute right heart failure/
PAH in patients in the setting of undiagnosed systemic 
inflammatory illness.
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FIGURE 1. A, Intermediate power magnification photomicrograph of lung section showing hyaline membranes (arrows) 
diagnostic of diffuse alveolar damage (H&E, ×200). B, High-power magnification photomicrograh illustrates increased cellularity 
of the alveolar septa. Indeed, numerous cells are present within the capillaries (arrows) (H&E, ×400). C, The cells are discohe-
sive suggesting lymphocytes with significant atypia and increased mitosis (arrows) (H&E, ×600). D, The immunostain for CD20 
confirms the atypical cells are B-lymphocytes supporting the diagnosis (CD20, 400×). H&E, hematoxylin and eosin.
